The article discusses the poor performance of Biogen Inc. (NASDAQ:BIIB) in 2024 compared to other NASDAQ stocks. Factors impacting stock market momentum include AI, earnings, interest rates, and geopolitical tensions. Despite setbacks, Biogen aims to cut costs and introduce new products.